RICHARD PAUL BRYCE

CIK 1553037 · Chief Medical Officer · last filed 2023-12-04

RICHARD PAUL BRYCE is a Chief Medical Officer who has filed 54 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for ENGNW, was dated Dec 4, 2023. Across all open-market trades the lifetime net is −$4.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.16M

Companies

3

Total Filings

54

Lifetime Open-Market Net

-$4.82M

Filer Profile

Reported Address

C/O PUMA BIOTECHNOLOGY, INC.
10880 WILSHIRE BOULEVARD, SUITE 2150
LOS ANGELES, CA 90024

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ENGNW	Chief Medical Officer	—	$0.23	—	$0	1	2023-12-04
RAIN	Chief Medical Officer	—	$0.85	—	$0	2	2023-02-17
PBYI	SEE REMARKS	121,662	$9.55	$1.16M	-$4.82M	50	2021-04-06

Recent Filings

54 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-12-04	ENGNW	Grant (A)	—	$0	EDGAR
2023-02-17	RAIN	Grant (A)	—	$0	EDGAR
2022-02-04	RAIN	Grant (A)	—	$0	EDGAR
2021-04-06	PBYI	Sell (S)	−426	-$4.2K	EDGAR
2021-03-04	PBYI	Sell (S)	−422	-$4.3K	EDGAR
2021-02-19	PBYI	Grant (A)	+52,846	$0	EDGAR
2021-02-03	PBYI	Sell (S)	−415	-$5.1K	EDGAR
2021-01-06	PBYI	Sell (S)	−6,548	-$67.0K	EDGAR
2020-12-04	PBYI	Sell (S)	−92	-$1.1K	EDGAR
2020-11-03	PBYI	Sell (S)	−97	-$758	EDGAR

Showing 1–10 of 54

Page 1 of 6 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.